X
Log In
Username or E-mail:
Password:
EULA
Log In
Forgot Password
Sign Up
Sign Up
Username:
E-mail:
Password:
EULA
Sign Up
Forgot Password
Already a Member
Username or E-mail
Send Forgot Mail
Back to Login
EULA
X
Share This!
Sign Up
Log In
Logout
X
English Türkçe

IPHA

Closed

Innate Pharma

1.845
+0.030 (+1.65%)
Last Update: 01 Jul 2025 23:01:00
Yesterday: 1.815
Day's Range: 1.7701 - 1.845
Send
When Written:
 
3.18
Innate Pharma is a French biotechnology company that specializes in the development of immunotherapy drugs to treat cancer and other diseases. The company was founded in 1999 and is headquartered in Marseille, France. Innate Pharma's drug development pipeline includes both monoclonal antibodies and small molecule drugs that target the immune system to fight cancer. The company's lead product candidate is called lirilumab, which is being developed for the treatment of various types of cancer. Innate Pharma has collaborations with several pharmaceutical companies, including Bristol-Myers Squibb, AstraZeneca, and Sanofi. The company is publicly traded on the Euronext Paris stock exchange under the ticker symbol IPH.

Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
Contact with us

Mail:
Message:
Cancel
Send
IP Adresiniz:216.73.216.58
X